I-Mab (IMAB)
USD 0.95
(8.63%)
USD 0.95
(8.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.21 Billion CNY | 37.65% |
| 2022 | -1.94 Billion CNY | 5.51% |
| 2021 | -2.05 Billion CNY | -1322.44% |
| 2020 | 168.31 Million CNY | 111.57% |
| 2019 | -1.45 Billion CNY | -236.92% |
| 2018 | -431.89 Million CNY | -54.62% |
| 2017 | -279.32 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -84.63 Million CNY | 69.35% |
| 2024 Q2 | -109.05 Million CNY | 82.27% |
| 2023 Q3 | -275.78 Million CNY | -445.99% |
| 2023 Q1 | -50.51 Million CNY | 91.11% |
| 2023 FY | - CNY | 37.65% |
| 2023 Q4 | -276.13 Million CNY | -0.13% |
| 2023 Q2 | -50.51 Million CNY | 0.0% |
| 2022 Q1 | -404.12 Million CNY | 22.04% |
| 2022 Q4 | -568.17 Million CNY | 0.04% |
| 2022 Q3 | -568.4 Million CNY | -40.65% |
| 2022 Q2 | -404.12 Million CNY | 0.0% |
| 2022 FY | - CNY | -3.27% |
| 2021 Q4 | -518.38 Million CNY | 0.0% |
| 2021 Q1 | -505.49 Million CNY | -143.21% |
| 2021 Q2 | -505.49 Million CNY | 0.0% |
| 2021 Q3 | -518.38 Million CNY | -2.55% |
| 2021 FY | - CNY | -582.27% |
| 2020 Q4 | 1.16 Billion CNY | 397.73% |
| 2020 Q1 | -304.29 Million CNY | 8.03% |
| 2020 Q2 | -304.29 Million CNY | 0.0% |
| 2020 FY | - CNY | 134.13% |
| 2020 Q3 | -392.91 Million CNY | -29.12% |
| 2019 Q2 | -410.1 Million CNY | 0.0% |
| 2019 FY | - CNY | -270.63% |
| 2019 Q4 | -330.86 Million CNY | -8.81% |
| 2019 Q3 | -304.06 Million CNY | 25.86% |
| 2019 Q1 | -410.1 Million CNY | -235.57% |
| 2018 Q1 | -99.31 Million CNY | 0.0% |
| 2018 Q2 | -99.31 Million CNY | 0.0% |
| 2018 Q3 | -111.05 Million CNY | -11.82% |
| 2018 Q4 | -122.21 Million CNY | -10.04% |
| 2018 FY | - CNY | -31.52% |
| 2017 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Absci Corporation | -95.45 Million USD | -1169.755% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -540.382% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -369.354% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -12159.347% |
| Apollomics, Inc. | -171.74 Million USD | -605.73% |
| 180 Life Sciences Corp. | -22.13 Million USD | -5376.048% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -3765.759% |
| Bicycle Therapeutics plc | -183.4 Million USD | -560.889% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -1520.092% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -632.718% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -5527.327% |
| Chimerix, Inc. | -92.97 Million USD | -1203.666% |
| CRISPR Therapeutics AG | -202.7 Million USD | -497.96% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 5241.772% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -1656.598% |
| Fortress Biotech, Inc. | -133.64 Million USD | -806.946% |
| Fortress Biotech, Inc. | -133.64 Million USD | -806.946% |
| Gritstone bio, Inc. | -126.86 Million USD | -855.416% |
| Allakos Inc. | -189.91 Million USD | -538.217% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -2400.299% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -930.234% |
| Cytokinetics, Incorporated | -456.68 Million USD | -165.407% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -1178.933% |
| Innoviva, Inc. | 248.96 Million USD | 586.853% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -791331.874% |
| NLS Pharmaceutics AG | -11.79 Million USD | -10175.563% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -863.137% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -9406809.954% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -1085.213% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -1270.081% |
| ImmuCell Corporation | -2.5 Million USD | -48303.863% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -829.352% |
| Incyte Corporation | 919.42 Million USD | 231.829% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -829.566% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -18872.314% |
| Mustang Bio, Inc. | -48.06 Million USD | -2421.836% |
| MiMedx Group, Inc. | 40.51 Million USD | 3091.51% |
| MEI Pharma, Inc. | 26.38 Million USD | 4694.655% |
| MacroGenics, Inc. | 2.01 Million USD | 60192.712% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 282608.117% |
| Mereo BioPharma Group plc | -26.05 Million USD | -4551.788% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -10178.511% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -865.816% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 270.137% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -5487.783% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -7532.683% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -11299.135% |
| NextCure, Inc. | -59.03 Million USD | -1952.999% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -2266.446% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -12059.611% |
| Onconetix, Inc. | -36.7 Million USD | -3202.038% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 54331.32% |
| Opthea Limited | -200.01 Million USD | -505.978% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -1964.392% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -43949.964% |
| PDS Biotechnology Corporation | -40.08 Million USD | -2923.752% |
| Precigen, Inc. | -89.22 Million USD | -1258.427% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -5224.971% |
| Prime Medicine, Inc. | -193.75 Million USD | -525.555% |
| PureTech Health plc | -11.62 Million USD | -10324.615% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -412.239% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 126.042% |
| Replimune Group, Inc. | -230.19 Million USD | -426.534% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -1272975.792% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -7037.801% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -6643.669% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -181.496% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -4926.854% |
| Sesen Bio, Inc. | -50.84 Million USD | -2284.087% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -1286.379% |
| Solid Biosciences Inc. | -93.43 Million USD | -1197.247% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -427.12% |
| SciSparc Ltd. | -5.28 Million USD | -22847.179% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -1684.687% |
| TG Therapeutics, Inc. | 26.1 Million USD | 4743.946% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -962.39% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -16816.539% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -271.52% |
| UroGen Pharma Ltd. | -63.83 Million USD | -1798.874% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -1848.76% |
| XOMA Corporation | -39.36 Million USD | -2979.29% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -339.948% |
| AbCellera Biologics Inc. | -192.15 Million USD | -530.767% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -2035.656% |
| Cassava Sciences, Inc. | -95.68 Million USD | -1166.703% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -2627.633% |
| Precision BioSciences, Inc. | -32.04 Million USD | -3682.754% |
| Dyadic International, Inc. | -8.22 Million USD | -14627.928% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -11917.351% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -416418.9% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -4042.696% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -889.396% |
| IGM Biosciences, Inc. | -253.35 Million USD | -378.402% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -1031.686% |
| Acelyrin, Inc. | -381.52 Million USD | -217.69% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -2296.722% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 1291.493% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -5987.013% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -4915.6% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -671.061% |
| Senti Biosciences, Inc. | -61.33 Million USD | -1876.115% |
| Mesoblast Limited | -61.33 Million USD | -1876.276% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -746.412% |
| ChromaDex Corporation | -3.89 Million USD | -31026.605% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -25196.433% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -17548.078% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 490387.845% |
| Seer, Inc. | -97.88 Million USD | -1138.259% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -5006.678% |
| Novavax, Inc. | -487.39 Million USD | -148.686% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -53776.506% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -603.755% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -2224.289% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -438.102% |
| Celcuity Inc. | -58.3 Million USD | -1978.667% |
| ContextLogic Inc. | -324 Million USD | -274.096% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -662.073% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -1467.136% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 183.624% |
| Amarin Corporation plc | -50.9 Million USD | -2281.205% |
| AnaptysBio, Inc. | -143.16 Million USD | -746.63% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -4181.269% |
| Aptorum Group Limited | -9.59 Million USD | -12527.048% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -415.634% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -589.962% |
| Ardelyx, Inc. | -55.35 Million USD | -2089.67% |
| Celularity Inc. | -183.94 Million USD | -558.927% |
| Omeros Corporation | -163.61 Million USD | -640.829% |
| Humacyte, Inc. | -96.45 Million USD | -1156.578% |
| Immunocore Holdings plc | -59.64 Million USD | -1932.004% |
| IO Biotech, Inc. | -91.22 Million USD | -1228.616% |
| GT Biopharma, Inc. | 5.97 Million USD | 20372.119% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -1555.065% |
| Summit Therapeutics Inc. | 1 Million USD | 121185.914% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -3822.049% |
| Pulmatrix, Inc. | -12.64 Million USD | -9484.612% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -139.39% |
| Evogene Ltd. | -23.2 Million USD | -5123.539% |
| CorMedix Inc. | -48.88 Million USD | -2379.328% |
| BioLineRx Ltd. | -57.06 Million USD | -2024.165% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -3634.847% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -3842.973% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -266.916% |
| scPharmaceuticals Inc. | -46.06 Million USD | -2531.445% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -1017.198% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 1218.93% |
| NLS Pharmaceutics AG | -11.79 Million USD | -10175.563% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -4926.854% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -715.489% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -8777.683% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -4649.677% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -979.276% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -1373.946% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -2012.506% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -6705.68% |
| Daré Bioscience, Inc. | -30.7 Million USD | -3847.916% |
| bluebird bio, Inc. | -167.16 Million USD | -625.091% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 490.632% |
| DBV Technologies S.A. | -85.98 Million USD | -1309.679% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -419.094% |
| Galecto, Inc. | -37.51 Million USD | -3130.55% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -3530.474% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -2458.945% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -486.411% |
| GlycoMimetics, Inc. | -39.12 Million USD | -2998.181% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -432.933% |
| ADMA Biologics, Inc. | 5.12 Million USD | 23773.242% |
| Clene Inc. | -43.24 Million USD | -2703.057% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -304.609% |
| Aptose Biosciences Inc. | -52.26 Million USD | -2218.952% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -1024.96% |
| Soligenix, Inc. | -7.85 Million USD | -15334.778% |
| Century Therapeutics, Inc. | -121.2 Million USD | -899.992% |
| Kura Oncology, Inc. | -164.95 Million USD | -634.788% |
| Surrozen, Inc. | -41.13 Million USD | -2846.853% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -1413.234% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -126455.356% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -28028.8% |
| Autolus Therapeutics plc | -156.77 Million USD | -673.152% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -1331.742% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -5980.415% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -977.07% |
| GRI Bio, Inc. | -10.89 Million USD | -11021.949% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -26741.154% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -1606.564% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -1067.787% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -3078.515% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -7806.055% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -14633.957% |
| Jaguar Health, Inc. | -33.13 Million USD | -3558.417% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -7598.986% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -2032.237% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -5156.614% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -355.671% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -524.975% |
| Verastem, Inc. | -83.16 Million USD | -1357.41% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -666.028% |
| Histogen Inc. | -10.5 Million USD | -11440.227% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -8388.059% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -1687.002% |
| Surrozen, Inc. | -41.13 Million USD | -2846.853% |
| Organovo Holdings, Inc. | -14.8 Million USD | -8086.343% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 37794612.005% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -14436.691% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -629.872% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -2360.633% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -7950.926% |
| Kronos Bio, Inc. | -121.83 Million USD | -894.886% |
| Turnstone Biologics Corp. | -56.23 Million USD | -2055.404% |
| Synaptogenix, Inc. | -8.3 Million USD | -14490.057% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -7801.884% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -377491.9% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -1822.486% |
| Exelixis, Inc. | 196.6 Million USD | 716.509% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -757.138% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -144.758% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -1765.153% |
| ESSA Pharma Inc. | -26.45 Million USD | -4481.576% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -30202.159% |
| Avid Bioservices, Inc. | -11.48 Million USD | -10457.181% |
| Insmed Incorporated | -654.73 Million USD | -85.123% |
| MediWound Ltd. | -4.89 Million USD | -24671.51% |
| OmniAb, Inc. | -49.73 Million USD | -2337.252% |
| Alector, Inc. | -142.89 Million USD | -748.242% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -1318.721% |
| Zai Lab Limited | -366.57 Million USD | -230.649% |
| AlloVir, Inc. | -190.14 Million USD | -537.442% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -317.039% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -1004.412% |
| Aura Biosciences, Inc. | -83.69 Million USD | -1348.182% |
| Immunic, Inc. | -99.11 Million USD | -1122.93% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -820.536% |
| Veracyte, Inc. | -49.4 Million USD | -2353.136% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -17058.576% |
| FibroGen, Inc. | -261.4 Million USD | -363.675% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -10779.365% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 1496.201% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -17212.001% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -6375.817% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -4667.8% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 3138.531% |
| Fortrea Holdings Inc. | 167.3 Million USD | 824.489% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -802.644% |
| XBiotech Inc. | -35.76 Million USD | -3288.889% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -1765.153% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -696.487% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 229224.764% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -1757.579% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -1060.375% |
| Agenus Inc. | -145.92 Million USD | -730.617% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -4621.37% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -2865.889% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -134.691% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -2063.599% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -941.879% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -5367.273% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -892.662% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -21835.743% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -4673.433% |
| Lantern Pharma Inc. | -15.78 Million USD | -7577.797% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| Ainos, Inc. | -8.77 Million USD | -13715.758% |
| Pluri Inc. | -20.22 Million USD | -5892.93% |
| Prothena Corporation plc | -190.1 Million USD | -537.569% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -845.467% |
| Rallybio Corporation | -72.37 Million USD | -1574.754% |
| Kodiak Sciences Inc. | -259.02 Million USD | -367.939% |
| Cue Biopharma, Inc. | -46.05 Million USD | -2531.96% |
| MeiraGTx Holdings plc | -57.05 Million USD | -2024.5% |
| Annexon, Inc. | -141.57 Million USD | -756.133% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -1788.077% |
| Moderna, Inc. | -3.28 Billion USD | 63.08% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -6156.814% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -4874.636% |
| Blueprint Medicines Corporation | -474.61 Million USD | -155.381% |
| Immix Biopharma, Inc. | -16.13 Million USD | -7411.754% |
| CalciMedica, Inc. | -34.18 Million USD | -3445.205% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -784.148% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -619.539% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -1961.694% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -380.237% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -3576.728% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -1097.52% |
| Nutriband Inc. | -5.12 Million USD | -23565.029% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -2701.049% |
| Vor Biopharma Inc. | -114.37 Million USD | -959.77% |
| Roivant Sciences Ltd. | -996.51 Million USD | -21.631% |
| Alkermes plc | 495.04 Million USD | 344.838% |
| ProKidney Corp. | -147.66 Million USD | -720.802% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -1778.159% |
| Arcellx, Inc. | -64.14 Million USD | -1789.578% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | -114.348% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -984.549% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -599934.653% |
| Atai Life Sciences N.V. | -36.31 Million USD | -3238.024% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -1424.291% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -1390.623% |
| MediciNova, Inc. | -9.87 Million USD | -12167.952% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -862.411% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -79109.855% |
| GeoVax Labs, Inc. | -26.66 Million USD | -4444.904% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -438.719% |
| Biomea Fusion, Inc. | -124.62 Million USD | -872.613% |
| RenovoRx, Inc. | -11.39 Million USD | -10541.528% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -536.795% |
| Geron Corporation | -174.78 Million USD | -593.475% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -3936.869% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -1031.528% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -419.141% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -5203.303% |
| Royalty Pharma plc | 1.88 Billion USD | 164.223% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -483.186% |
| Imunon, Inc. | -19.87 Million USD | -5997.459% |
| BioAtla, Inc. | -122.24 Million USD | -891.541% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -303.629% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -2824.385% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -629.811% |
| Structure Therapeutics Inc. | -102.45 Million USD | -1082.981% |
| 89bio, Inc. | -134.46 Million USD | -801.415% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -1121.18% |
| aTyr Pharma, Inc. | -52.17 Million USD | -2222.952% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -1346.125% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -416.731% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -14971.186% |
| Akari Therapeutics, Plc | -16.8 Million USD | -7113.844% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 642406.021% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 368.189% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -641.49% |
| Liquidia Corporation | -70.05 Million USD | -1630.268% |
| Entera Bio Ltd. | -8.8 Million USD | -13667.265% |
| GH Research PLC | -41.15 Million USD | -2845.277% |
| Vericel Corporation | 2.86 Million USD | 42420.88% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -1607.478% |
| Xencor, Inc. | -125.87 Million USD | -862.923% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -84865.423% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -7806.055% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -5912.962% |
| Vaxcyte, Inc. | -464.88 Million USD | -160.725% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -475.77% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -10977.225% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -18872.314% |
| Portage Biotech Inc. | -18.19 Million USD | -6560.091% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -79109.855% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -1058.944% |
| OncoCyte Corporation | -23.12 Million USD | -5141.837% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -10625.94% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -10479.445% |
| Purple Biotech Ltd. | -22.22 Million USD | -5353.633% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -4112.086% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -4084.891% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -619.483% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -18809.048% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -4008.155% |
| United Therapeutics Corporation | 1.38 Billion USD | 187.4% |
| HilleVax, Inc. | -132.46 Million USD | -815.005% |
| Silo Pharma, Inc. | -3.62 Million USD | -33325.22% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -19716.249% |
| Pharming Group N.V. | 9.87 Million USD | 12371.641% |
| Tharimmune, Inc. | -9.3 Million USD | -12929.384% |
| Genprex, Inc. | -31.06 Million USD | -3802.279% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -1343.198% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -546.348% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -1444.176% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -158547.906% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 803306.012% |
| OKYO Pharma Limited | -15.74 Thousand USD | -7697601.048% |
| Savara Inc. | -59.13 Million USD | -1949.735% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -5912.55% |
| Curis, Inc. | -45.13 Million USD | -2585.195% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -7878.791% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -4433.815% |
| BeiGene, Ltd. | -1.12 Billion USD | -7.777% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -1241.676% |
| Erasca, Inc. | -121.31 Million USD | -899.151% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -26842.337% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -26842.337% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -2744.634% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -21360.163% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -1925.112% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -771.78% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -488.784% |
| Adicet Bio, Inc. | -136.53 Million USD | -787.736% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -1216.337% |
| Aditxt, Inc. | -25.45 Million USD | -4661.064% |
| Adagene Inc. | -14.95 Million USD | -8007.066% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -16480.763% |
| Quantum-Si incorporated | -91.8 Million USD | -1220.28% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 1058.499% |
| Compugen Ltd. | -12.51 Million USD | -9584.164% |
| Generation Bio Co. | -133.3 Million USD | -809.28% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -1359.798% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -1309.007% |
| Invivyd, Inc. | -196.61 Million USD | -516.469% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -223.95% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -12968.425% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 4563.689% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -11684.832% |
| 2seventy bio, Inc. | -206.41 Million USD | -487.192% |
| Instil Bio, Inc. | -146.12 Million USD | -729.492% |
| Capricor Therapeutics, Inc. | -23 Million USD | -5167.814% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -28283.434% |
| GeoVax Labs, Inc. | -26.66 Million USD | -4444.904% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -3200.004% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 24784.461% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -665.176% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -77.124% |
| Evaxion Biotech A/S | -21.4 Million USD | -5563.085% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -1724.994% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -456.841% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -1422.854% |
| Cingulate Inc. | -22.95 Million USD | -5180.883% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -16145.409% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -3150.999% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -1976.458% |
| Clearmind Medicine Inc. | -8.71 Million USD | -13814.785% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -1530.397% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -49546.23% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -1102.128% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -218.992% |
| ImmunityBio, Inc. | -436.18 Million USD | -177.882% |
| Korro Bio, Inc. | -80.9 Million USD | -1398.158% |
| Kineta, Inc. | -15.71 Million USD | -7613.313% |
| BioVie Inc. | -31.95 Million USD | -3693.622% |
| Codexis, Inc. | -49.28 Million USD | -2359.408% |
| Celularity Inc. | -183.94 Million USD | -558.927% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -7663.21% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -447.185% |
| Virax Biolabs Group Limited | -6.6 Million USD | -18239.289% |
| Cibus, Inc. | -314.58 Million USD | -285.292% |
| IN8bio, Inc. | -28.5 Million USD | -4152.28% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -976.448% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -4235.79% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -426.964% |
| Eyenovia, Inc. | -24.1 Million USD | -4928.077% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 2806.48% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -373995.679% |
| Elevation Oncology, Inc. | -41.46 Million USD | -2822.975% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -1542.282% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -2592.651% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -881.624% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -3824.843% |
| Moolec Science SA | -52.07 Million USD | -2227.523% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -2248.7% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -2898.911% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -913.496% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -2400.505% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -12899.11% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -5743.905% |
| Humacyte, Inc. | -96.45 Million USD | -1156.578% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -1436.697% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 30012.883% |
| Genelux Corporation | -24.16 Million USD | -4915.808% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -3486.006% |
| Notable Labs, Ltd. | -14.4 Million USD | -8317.153% |
| Immunovant, Inc. | -269.97 Million USD | -348.951% |
| Quantum-Si incorporated | -91.8 Million USD | -1220.28% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -6177.553% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -1088.164% |
| Acasti Pharma Inc. | -11.3 Million USD | -10625.334% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -5346.712% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -3173.211% |
| PepGen Inc. | -83.58 Million USD | -1350.157% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -5193.576% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -25301.028% |
| Immuneering Corporation | -58.06 Million USD | -1987.587% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 37794612.005% |
| Belite Bio, Inc | -31.52 Million USD | -3744.302% |
| XOMA Corporation | -39.36 Million USD | -2979.29% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -1697.07% |
| Bionomics Limited | -9.83 Million USD | -12221.547% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -3402.485% |
| uniQure N.V. | -253.1 Million USD | -378.89% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -16480.763% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -835.932% |
| Forte Biosciences, Inc. | -32.47 Million USD | -3632.087% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -14955.886% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -4195.227% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -373995.679% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -10779.365% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -7522.602% |
| Altimmune, Inc. | -87.93 Million USD | -1278.37% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -891.517% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -3402.485% |
| Peak Bio, Inc. | -1356.23 USD | -89370434.496% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -2394.074% |
| Benitec Biopharma Inc. | -22.49 Million USD | -5289.373% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -400.229% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -4146.47% |
| Zura Bio Limited | -60.56 Million USD | -1901.337% |
| PolyPid Ltd. | -20.26 Million USD | -5881.691% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -4146.47% |
| argenx SE | -216.02 Million USD | -461.084% |
| Immunome, Inc. | -28.27 Million USD | -4187.326% |
| Verona Pharma plc | -52.46 Million USD | -2210.131% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -1178.933% |
| Shattuck Labs, Inc. | -87.61 Million USD | -1283.405% |
| CervoMed Inc. | -2.17 Million USD | -55707.565% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -9449.122% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -2416.025% |
| Moolec Science SA | -52.07 Million USD | -2227.523% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -6971.594% |
| Design Therapeutics, Inc. | -66.32 Million USD | -1727.471% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -1396.623% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -3110.781% |
| Achilles Therapeutics plc | -70.44 Million USD | -1620.664% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -49546.23% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -2086.589% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -2297.765% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -1756.81% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -2140.014% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -2571.17% |
| Beam Therapeutics Inc. | -156.47 Million USD | -674.619% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -788.028% |
| AEON Biopharma, Inc. | -48.36 Million USD | -2406.296% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -1754.31% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -1379.361% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -9714.314% |
| NeurAxis, Inc. | -6.66 Million USD | -18086.974% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -183.57% |
| Lumos Pharma, Inc. | -36.57 Million USD | -3214.383% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 20892.909% |
| Palisade Bio, Inc. | -12.28 Million USD | -9769.473% |
| Nutriband Inc. | -5.12 Million USD | -23565.029% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -1052.191% |
| Neurogene Inc. | -52.28 Million USD | -2218.154% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -14336.279% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -1203.049% |
| Athira Pharma, Inc. | -116.7 Million USD | -938.594% |
| HCW Biologics Inc. | -23.57 Million USD | -5041.106% |
| XOMA Corporation | -39.36 Million USD | -2979.29% |
| Nektar Therapeutics | -243.1 Million USD | -398.575% |
| Arvinas, Inc. | -394.8 Million USD | -207.009% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 642406.021% |
| Merus N.V. | -149.2 Million USD | -712.341% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -1196.47% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -3777.383% |
| Rezolute, Inc. | -68.42 Million USD | -1671.437% |
| Clene Inc. | -43.24 Million USD | -2703.057% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -7759.26% |
| BeyondSpring Inc. | -21.54 Million USD | -5527.066% |
| Synlogic, Inc. | -55.16 Million USD | -2097.331% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -9931.201% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -11289.494% |
| Peak Bio, Inc. | -1356.23 USD | -89370434.496% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -3633.467% |
| Krystal Biotech, Inc. | 17.9 Million USD | 6869.828% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -923.509% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -255.085% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -26212.556% |
| MannKind Corporation | 15.12 Million USD | 8111.567% |
| Ikena Oncology, Inc. | -74.39 Million USD | -1529.192% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -9524.95% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 6062.857% |
| Gossamer Bio, Inc. | -172.15 Million USD | -604.07% |
| CohBar, Inc. | -12.06 Million USD | -9945.535% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -4651.539% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -3936.869% |
| Legend Biotech Corporation | -477.87 Million USD | -153.639% |
| Mural Oncology plc | -192.72 Million USD | -528.928% |
| Disc Medicine, Inc. | -91.02 Million USD | -1231.579% |
| Champions Oncology, Inc. | -5.05 Million USD | -23882.39% |
| REGENXBIO Inc. | -239.46 Million USD | -406.16% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -11208.536% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -2073.883% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -3026.449% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -974.473% |
| Vaxart, Inc. | -74.72 Million USD | -1522.084% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -3342.569% |
| Cellectis S.A. | -98.09 Million USD | -1135.608% |
| Longeveron Inc. | -20.06 Million USD | -5942.223% |
| Repare Therapeutics Inc. | -114.27 Million USD | -960.679% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -175.975% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -1520.155% |
| Revolution Medicines, Inc. | -430.58 Million USD | -181.496% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -19172.857% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -3836.698% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -1524.977% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 24820.987% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -10953.99% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 126.32% |
| Denali Therapeutics Inc. | -179.97 Million USD | -573.473% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -1272975.792% |
| Veru Inc. | -89.97 Million USD | -1247.11% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -4409.525% |
| Cingulate Inc. | -22.95 Million USD | -5180.883% |
| Passage Bio, Inc. | -98.34 Million USD | -1132.517% |
| Context Therapeutics Inc. | -25.06 Million USD | -4736.562% |
| Exicure, Inc. | -15.53 Million USD | -7700.18% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -488.201% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -3177.991% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -20227.891% |
| Nuvalent, Inc. | -149.49 Million USD | -710.793% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -14804.183% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -1311.123% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -3916.403% |
| OmniAb, Inc. | -49.73 Million USD | -2337.252% |
| Anew Medical, Inc. | -1.3 Million USD | -93075.948% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -9703.219% |
| Lipocine Inc. | -16.32 Million USD | -7325.686% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -1718.014% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -1531.253% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -3078.515% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -3006.757% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -5363.959% |
| Sage Therapeutics, Inc. | -545.07 Million USD | -122.37% |
| Ocugen, Inc. | -64.82 Million USD | -1769.699% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -1209.355% |
| Q32 Bio Inc. | -86.5 Million USD | -1301.205% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -7060.572% |
| Alumis Inc. Common Stock | -156.89 Million USD | -672.56% |
| Equillium, Inc. | -12.13 Million USD | -9885.747% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -1972.907% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -15236.157% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -6326.338% |
| Dominari Holdings Inc. | -22.44 Million USD | -5301.381% |
| Edesa Biotech, Inc. | -8.19 Million USD | -14699.133% |
| vTv Therapeutics Inc. | -25.41 Million USD | -4669.676% |
| Bio-Techne Corporation | 326.66 Million USD | 471.046% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -214.935% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 660.135% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -824.482% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -3138.145% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -702.159% |
| Nkarta, Inc. | -120.48 Million USD | -906.026% |
| BioCardia, Inc. | -11.56 Million USD | -10385.035% |
| Iterum Therapeutics plc | -34.58 Million USD | -3405.119% |